Impax Laboratories Inc. (IPXL)

17.90
0.22 1.24
NYSE : Health Technology
Prev Close 17.68
Open 17.72
Day Low/High 17.50 / 18.29
52 Wk Low/High 13.47 / 18.29
Volume 839.29K
Avg Volume 916.90K
Exchange NYSE
Shares Outstanding 73.87M
Market Cap 1.35B
EPS -6.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Impax Laboratories Receives Tentative FDA Approval For Generic Opana® ER 5, 7.5, 10, 15, 20, 30 And 40 Mg Tablets

Impax Laboratories, Inc. (NASDAQ: IPXL) today confirmed that the U.

Impax Laboratories To Present At The Bank Of America Merrill Lynch Health Care Conference

Impax Laboratories, Inc. (NASDAQ:IPXL) today announced that the Company will provide an update of their business at the Bank of America Merrill Lynch Health Care Conference on Thursday, May 13 th, at 10:00 a.

Impax Laboratories Inc. Q1 2010 Earnings Call Transcript

Impax Laboratories Inc. Q1 2010 Earnings Call Transcript

Impax Laboratories Reports Significant Growth For The First Quarter 2010

Impax Laboratories, Inc. (NASDAQ:IPXL) today reported significant growth in the first quarter of 2010 due to an increase in sales from its Global product sales channel.

Impax Laboratories To Present At The Deutsche Bank 35th Annual Health Care Conference

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will provide an update of their business at the Deutsche Bank 35 th Annual Health Care Conference on Wednesday, May 5 th, at 9:20 a.

Impax Laboratories Confirms Patent Challenge Relating To Fenoglide® 40 And 120 Mg Tablets

Impax Laboratories, Inc. (NASDAQ:IPXL) today confirms that it has initiated a challenge of a patent listed by Shionogi Pharma, Inc.

Impax Pharmaceuticals Announces Amendment Of Co-Promotion Agreement

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc.

Impax Pharmaceuticals Completes Enrollment In APEX-PD Phase III Trial Of IPX066 In Parkinson’s Disease

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc.

Allen Chao, Ph.D. Elected To Impax Laboratories Board Of Directors

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that Allen Chao, Ph.

Five Small-Cap Giants for Earnings Season

Internet Gold-Golden Lines and IMAX are among the small-cap stocks that could give your portfolio large gains in coming weeks.

Impax Laboratories Schedules Conference Call For First Quarter 2010 Financial Results

Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its first quarter 2010 financial results will be released before the market opens on Tuesday, May 4, 2010 and will be available on Impax’s Web site at...

Impax Laboratories To Present At The Barclays Capital 2010 Global Healthcare Conference

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will provide an update of their business at the Barclays Capital 2010 Global Healthcare Conference on Tuesday, March 23 rd, at 5:15 p.

Impax Laboratories Confirms Patent Challenge Relating To TRILIPIX® Delayed-Release Capsules, 135 Mg And 45 Mg

Impax Laboratories, Inc. (NASDAQ: IPXL) today confirms that it has initiated a challenge of the patent listed by Abbott Laboratories and Fournier Laboratories Ireland Ltd.

Impax Laboratories To Present At The Cowen & Co. 30th Annual Health Care Conference On March 9, 2010

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will provide an update of their business at the Cowen & Co.

Impax Laboratories Receives Final FDA Approval For Generic FLOMAX® 0.4mg Capsules And Immediately Commences Shipment

Impax Laboratories Receives Final FDA Approval For Generic FLOMAX® 0.4mg Capsules And Immediately Commences Shipment

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.

Impax Laboratories To Appear At The RBC Capital Markets Healthcare Conference On Tuesday, March 2, 2010

Impax Laboratories To Appear At The RBC Capital Markets Healthcare Conference On Tuesday, March 2, 2010

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that Arthur A.

Impax Buys Applications For 2 Watson Generics

Impax Buys Applications For 2 Watson Generics

Impax Labs buys rights to applications for generic version of Dronabinol and Dostinex

Abbott Suing Impax Labs Over Generic TriCor

Impax says it filed for approval of cholesterol drug, leading to patent suit from Abbott

Shire And Sandoz Settle Adderall XR Patent Suits

Shire And Sandoz Settle Adderall XR Patent Suits

Sandoz will be able to sell authorized generic of ADHD drug under settlement with Shire

Medicis Settles Solodyn Patent Lawsuit With Sandoz

Medicis Settles Solodyn Patent Lawsuit With Sandoz

Medicis settles Solodyn ER lawsuit with Sandoz; resolves the third of 4 patent challenges

FDA Approves Generic Diabetes Treatment For Impax

FDA approves generic version of diabetes treatment Precose for Impax Laboratories

Impax Sued By Genzyme In Patent Challenge

Impax Laboratories faces lawsuit from Genzyme in patent challenge to kidney drug Renvela

Medicis Shares Jump On Teva Solodyn Settlement

Medicis Pharmaceutical shares surge on Solodyn settlement with Teva Pharmaceutical

Warner Chilcott Sues Impax Over Acne Drug Doryx

Warner Chilcott says it sued Impax over generic 150 mg Doryx, triggering stay of FDA ruling

Medicis Resolves Acne Drug Patent Suit With Teva

Teva to launch generic acne drug Solodyn by Nov. 2011 under terms of settlement with Medicis

Teva Says It Launched Generic Version Of Acne Drug

Teva launches generic acne drug Solodyn, sending shares of maker Medicis to 11-year lows

Warner Chilcott Denied Stay On 2 Doryx Doses

Warner Chilcott Denied Stay On 2 Doryx Doses

Warner Chilcott says FDA won't delay rulings on 2 strengths of Doryx, but may halt a third

FDA OKs Impax Anxiety Drug

Its abbreviated new-drug application for Xanax XR is approved.

Health Stocks in Motion

Health Stocks in Motion

Durect rises after licensing pain-relief patch to Endo.

Quiet Please, Dow's High Is Within Reach

No one's cheering the index's ascent this time. Plus charts of the Nasdaq, Microsoft and more.